CARE Ratings Share Price Target 2026 Analyst Forecast Bull and Bear Case

CARE Ratings (NSE: CARERATING) is a Credit Rating and Research company trading at Rs 1,651 with a market capitalisation of Rs 4,951 crore. Analysts have set the CARE Ratings share price target at Rs 2,000 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for CARE Ratings including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

CARE Ratings Share Price Target 2026: Key Takeaways

• CARE Ratings share price target 2026: Rs 2,000 (20% upside from CMP Rs 1,651)
• Bull case: Rs 2,400 | Bear case: Rs 1,300
• Ticker: CARERATING | Sector: Credit Rating and Research | MCap: Rs 4,951 crore
• 52W range: Rs 1,143 to Rs 2,710 | PE: 25x
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

CARE Ratings Company Overview

CARE Ratings (NSE: CARERATING) is a Mumbai-based CARE Group credit rating agency providing corporate bond ratings, bank loan ratings, and structured finance ratings to 6,000-plus rated entities, with FY26 revenue growing 18 percent year-on-year on India’s corporate bond market expansion. At CMP Rs 1,651 against a 52 week range of Rs 1,143 to Rs 2,710, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 4,951 crore with trailing PE of 25x. Compared to peers in credit rating like ICRA and CRISIL, CARE Ratings is positioned as a potential re-rating candidate toward the Rs 2,000 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	CARERATING
Sector	Credit Rating and Research
CMP (2026)	Rs 1,651
52 Week High	Rs 2,710
52 Week Low	Rs 1,143
Market Cap	Rs 4,951 crore
Trailing PE	25x
12-Month Analyst Target	Rs 2,000
Bull Case Target	Rs 2,400
Bear Case Target	Rs 1,300

Why Is the CARE Ratings Share Price Target Set at Rs 2,000 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The CARE Ratings share price target of Rs 2,000 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 1,651. Until FY27 PAT delivery is confirmed, the Rs 2,000 objective represents a base case with execution risk attached.

Structural Sector Tailwinds in Credit Rating and Research

The Credit Rating and Research sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. CARE Ratings’s market position among peers in credit rating like ICRA and CRISIL creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 2,400 bull case to materialise, making sector monitoring essential for investors tracking the stock.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For CARE Ratings, lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 2,000 analyst consensus in 2026.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for CARE Ratings’s Credit Rating and Research operations. Policy support increases the probability of CARE Ratings achieving its FY27 earnings targets, supporting the Rs 2,000 price objective.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, CARE Ratings is positioned as a beneficiary of institutional reallocation into the Credit Rating and Research sector, providing a tailwind toward the Rs 2,400 bull case.

CARE Ratings Share Price Targets: Short Term, 12 Month, and Long Term

Short Term CARE Ratings Share Price Target

Near-term support for CARE Ratings is anchored close to the 52 week low of Rs 1,143. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a reference while awaiting the FY27 earnings confirmation that would support the full Rs 2,000 objective.

12-Month CARE Ratings Share Price Target 2026

The 12-month CARE Ratings share price target 2026 is Rs 2,000, implying approximately 20 percent upside from CMP Rs 1,651. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows into the Credit Rating and Research sector. Track live price on NSE under ticker CARERATING.

Long Term CARE Ratings Share Price Target: FY27 to FY28

The long term CARE Ratings share price target for FY27 to FY28 is Rs 2,400 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in credit rating like ICRA and CRISIL, and sustained institutional buying are the three conditions needed to reach Rs 2,400 over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for CARE Ratings in 2026

Bull Case CARE Ratings Share Price Target: Rs 2,400

The bull case CARE Ratings share price target of Rs 2,400 materialises when FY27 earnings beat analyst estimates, Credit Rating and Research tailwinds accelerate, and FII flows return strongly to Indian equities. Under this scenario, CARE Ratings re-rates toward higher peer multiples, making Rs 2,400 achievable within FY28, representing approximately 45 percent upside from the current CMP of Rs 1,651.

Bear Case CARE Ratings Share Price Target: Rs 1,300

The bear case CARE Ratings share price target of Rs 1,300 materialises if FY27 earnings disappoint or FII outflows depress the broader market. Under this scenario, the stock risks testing 52 week low support near Rs 1,143, and investors should reassess the thesis before deploying additional capital.

Scenario	Target	Key Conditions
Bull Case	Rs 2,400	FY27 earnings beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 2,000	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 1,300	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the CARE Ratings 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions triggered by the US reciprocal tariff announcement in 2026 have reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains a prominent macro risk to the CARE Ratings share price target of Rs 2,000 and could push the stock toward the bear case of Rs 1,300.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress multiples. This is the most direct company-specific risk to the Rs 2,000 analyst price objective. Investors should monitor quarterly results and management commentary, especially signals about demand environment, pricing power, and margin compression in Credit Rating and Research.

Competitive Intensity Among Credit Rating and Research Peers

Intensifying competition from peers in credit rating like ICRA and CRISIL could compress CARE Ratings’s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory is that underpins the Rs 2,000 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns. Investors should size positions carefully and maintain stop losses to protect capital if broader market de-rating continues.

How to Invest in CARE Ratings

Check the Univest Screener for live data

Before considering any investment based on the CARE Ratings share price target of Rs 2,000, review the company’s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Credit Rating and Research sector demand and competition.

Open a Demat and trading account with a SEBI registered stockbroker to trade CARE Ratings (NSE: CARERATING) with regulatory protection. Before executing any order, study the competitive landscape among peers in credit rating like ICRA and CRISIL to assess whether CARE Ratings’s competitive position justifies the Rs 2,000 valuation.

Plan your entry using the 52 week low of Rs 1,143 as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.

Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Credit Rating and Research space where sectoral cycles can amplify volatility beyond initial expectations.

Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track CARE Ratings’s live share price and receive daily stock recommendations from SEBI registered analysts.

FAQs on CARE Ratings Share Price Target 2026

What is the CARE Ratings share price target for 2026?

Ans. The CARE Ratings share price target 2026 is Rs 2,000, implying approximately 20 percent upside from CMP Rs 1,651. The bull case target is Rs 2,400 and the bear case is Rs 1,300.

What was the CARE Ratings share price target for 2025?

Ans. The 2025 price objective for CARE Ratings was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 2,000, reflecting FY27 growth potential from the current CMP of Rs 1,651.

Is CARE Ratings a good investment at Rs 1,651?

Ans. At Rs 1,651, CARE Ratings offers potential upside toward Rs 2,000 if FY27 earnings recover as projected. Whether this represents a good entry depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.

What are the key risks to the CARE Ratings share price target 2026?

Ans. Key risks to the CARE Ratings share price target of Rs 2,000 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Credit Rating and Research. Monitoring quarterly results and management guidance is essential.

What is the 52 week high and low of CARE Ratings?

Ans. The 52 week high of CARE Ratings is Rs 2,710 and the 52 week low is Rs 1,143. At CMP Rs 1,651, the stock is trading below its 52 week high and offers upside toward the Rs 2,000 analyst price objective.

What are the main growth catalysts for CARE Ratings in 2026?

Ans. Primary growth catalysts for CARE Ratings in 2026 include FY27 PAT recovery, Credit Rating and Research sector tailwinds, RBI rate cuts reducing cost of capital, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does CARE Ratings compare to its peers?

Ans. CARE Ratings operates in Credit Rating and Research alongside peers in credit rating like ICRA and CRISIL. At CMP Rs 1,651 with MCap Rs 4,951 crore, the company is positioned as a potential re-rating candidate toward the CARE Ratings share price target of Rs 2,000 on FY27 earnings delivery.

What is the CARE Ratings share price target for 2027?

Ans. The long-term CARE Ratings share price target for FY27 to FY28 is Rs 2,400 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.